Systems Biology Opens the Blackest Boxes
Systems Biologists Are Attacking the Encrypted Messages That Would Allow Us to Predict and Change the Course of Disease
Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
For full access to this article login to GEN Select now.
Utilizing Biomarkers to Their Full Extent
Identifying Markers Is Not Enough, Researchers Must Understand Their Attributes As Well
- The role of biomarkers in making personalized medicine a reality is captivating researchers despite development, clinical validation, and regulatory challenges. A recent BCC Research report estimates that the global biomarker market will reach $12.8 billion by 2012. Many companies and organizations covet a piece of this market and are ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.